Correspondence 0000950170-24-099072 from DURECT CORP (DRRX) (CIK 0001082038)
DURECT CORP (DRRX) (CIK 0001082038)
Date: Aug. 20, 2024 · CIK: 0001082038 · Accession: 0000950170-24-099072
AI Filing Summary & Sentiment
File numbers found in text: 333-281550
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
August 20, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky, Office of Life Sciences
Re:
DURECT Corporation
Registration Statement on Form S-
Filed August 14, 2024
File No. 333-281550
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Acceleration Request
Requested Date:
August 23, 2024
Requested Time:
4:00 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, DURECT Corporation (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-3 (File No. 333-281550) effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Company hereby authorizes Stephen Thau, who is an attorney with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.
The Company requests that it be notified of such effectiveness by a telephone call to Mr. Thau at (212) 506-5076.
[Signature page follows]
Sincerely,
DURECT CORPORATION
By:
/s/ Timothy M. Papp
Name: Timothy M. Papp
Title: Chief Financial Officer
cc:
James E. Brown, DURECT Corporation
Stephen Thau, Esq., Orrick, Herrington & Sutcliffe LLP